相关实验视频
Updated: Mar 29, 2026

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
使用L-RNA阿普塔默的微RNA处理的特定抑制
Jonathan T Sczepanski1, Gerald F Joyce1
1Department of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute , 10550 North Torrey Pines Road, La Jolla, California 92037, United States.
研究人员开发了微RNA (miRNA) 处理的胺抑制剂. 这些aptamiRs与前体miRNAs结合,阻断Dicer酶的活性并防止成熟miRNA的形成,从而提供了一种新的治疗策略.
科学领域:
- 生物化学
- 分子生物学
- 有关RNA疗法
背景情况:
- 微RNAs (miRNAs) 是基因表达的关键调节者.
- miRNAs的失调与包括癌症在内的各种疾病有关.
- 目前的miRNA抑制策略面临着核酶降解等挑战.
研究的目的:
- 开发针对前体微RNAs (pre- miRs) 的新型抑制剂.
- 研究 l-RNA 体作为 miRNA 处理抑制剂的潜力.
- 评估阿帕特抗癌药物对癌症前期药物的疗效.
主要方法:
- 在试验室中选择用于产生针对miR前目标的l-RNA体.
- 通过三级相互作用来表征阿普坦- 预- 米R结合.
- 测试阿帕特米R介导的Dicer处理的预米R.
- 在生理条件下确定抑制度50 (IC50) 值.
主要成果:
- 被称作aptamiRs的l-RNA的aptamers成功地被选择来结合特定的前miRs.
- 通过特定的三级相互作用,而不是沃森-克里克基配对.
- 形成aptamiR- pre- miR复合体有效抑制了Dicer介导的处理.
- 一种针对瘤前miR-155的aptamiR显示出强大的抑制作用,其IC50为87nM.
结论:
- AptamiRs 是一种能够抑制miRNA生物发生的新型分子.
- l-RNAs固有的核酶耐药性表明对aptamiRs的治疗潜力.
- AptamiRs为针对miRNA的治疗提供了一个有前途的新策略.
更多相关视频
06:53A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA
Published on: December 26, 2015
09:04Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
Published on: September 21, 2017
相关概念视频
MicroRNAs
MicroRNAs
Experimental RNAi
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...